Volume 2, Issue 6, Pages e243-e251 (June 2015)

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration  Alasdair Reid, MD, Fabio Scano,
Volume 357, Issue 9273, Pages (June 2001)
BMI and risk of dementia in two million people over two decades: a retrospective cohort study  Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.
Volume 6, Issue 7, Pages (July 2005)
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV- associated pulmonary tuberculosis before antiretroviral therapy:
Volume 4, Issue 10, Pages e465-e474 (October 2017)
Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study  Dr Brian G Williams, PhD, Somya Gupta, MA,
The Lancet Public Health
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV- associated pulmonary tuberculosis before antiretroviral therapy:
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
Volume 2, Issue 4, Pages e151-e158 (April 2015)
Volume 14, Issue 1, Pages (January 2015)
Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis  Katharina Kranzer,
Paediatric HIV-1 infection
Volume 13, Issue 12, Pages (December 2012)
Volume 371, Issue 9611, Pages (February 2008)
Volume 4, Issue 10, Pages e457-e464 (October 2017)
Volume 2, Issue 12, Pages e530-e539 (December 2015)
Volume 10, Issue 4, Pages (April 2009)
Midlife contributors to socioeconomic differences in frailty during later life: a prospective cohort study  Prof Eric J Brunner, PhD, Martin J Shipley,
Volume 379, Issue 9811, Pages (January 2012)
WHO's new guidelines for antiretroviral treatment
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study  Helen Booth, MSc, Omar Khan, FRCS, Prof Toby Prevost, PhD,
Socioeconomic disparities in first stroke incidence, quality of care, and survival: a nationwide registry-based cohort study of 44 million adults in England 
Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an.
Volume 9, Issue 10, Pages (October 2008)
Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study  Dr Brian G Williams, PhD, Somya Gupta, MA,
Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis  Manish Pareek, MRCP, John.
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
Alcohol use among young adolescents in low-income and middle-income countries: a population-based study  Chuanwei Ma, MSc, Pascal Bovet, MD, Lili Yang,
Volume 379, Issue 9835, Pages (June 2012)
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study  Jue Liu, PhD, Shikun Zhang, MD,
Volume 4, Issue 6, Pages (June 2017)
Volume 3, Issue 8, Pages e388-e396 (August 2016)
Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study  Prof Andy C Rawstron, PhD,
Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing  Dr.
The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective.
Volume 13, Issue 12, Pages (December 2012)
Volume 393, Issue 10171, Pages (February 2019)
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis  Dr Robert W Aldridge, MSc,
Volume 392, Issue 10144, Pages (July 2018)
HIV incidence in men who have sex with men in England and Wales 2001–10: a nationwide population study  Paul J Birrell, PhD, Prof O Noel Gill, FFPH, Valerie.
Forecasted trends in disability and life expectancy in England and Wales up to 2025: a modelling study  Dr Maria Guzman-Castillo, PhD, Sara Ahmadi-Abhari,
A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort.
Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study  Dr Robert.
Volume 378, Issue 9787, Pages (July 2011)
Volume 388, Issue 10061, Pages (December 2016)
Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)
Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries  Dr Noreen.
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study  Krishna P Reddy,
Low-technology approaches
Volume 3, Issue 2, Pages e94-e104 (February 2016)
Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study  Sabin Nsanzimana, MD, Eric Remera, MSc, Steve Kanters,
Epidemiology of stroke
Volume 375, Issue 9722, Pages (April 2010)
Volume 377, Issue 9777, Pages (May 2011)
Genital herpes—how much of a public-health problem?
Volume 373, Issue 9672, Pages (April 2009)
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Costs of eliminating HIV in South Africa have been underestimated
Volume 393, Issue 10177, Pages (March 2019)
Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment  Jonathan Pearson-Stuttard, BMBCh, Bin Zhou,
Volume 378, Issue 9799, Pages (October 2011)
Sputum culture conversion in new TB regimens
Volume 371, Issue 9611, Pages (February 2008)
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study  Gayatri Amirthalingam,
Presentation transcript:

Volume 2, Issue 6, Pages e243-e251 (June 2015) Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland  Dr Rishi K Gupta, MRCP, Brian Rice, MSc, Alison E Brown, PhD, H Lucy Thomas, MFPH, Dominik Zenner, MD, Laura Anderson, PhD, Debora Pedrazzoli, MSc, Anton Pozniak, MD, Prof Ibrahim Abubakar, FRCP, Valerie Delpech, FFPH, Marc Lipman, MD  The Lancet HIV  Volume 2, Issue 6, Pages e243-e251 (June 2015) DOI: 10.1016/S2352-3018(15)00063-6 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 1 Study entry and exit of individuals in HIV-positive cohort in England, Wales, and Northern Ireland, 2007–11 The Lancet HIV 2015 2, e243-e251DOI: (10.1016/S2352-3018(15)00063-6) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 2 Tuberculosis incidence by months on antiretroviral therapy in the national HIV cohort in England, Wales, and Northern Ireland Error bars represent 95% CIs. The Lancet HIV 2015 2, e243-e251DOI: (10.1016/S2352-3018(15)00063-6) Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure 3 Tuberculosis incidence in national HIV cohort compared with that in background HIV-negative population in 2009 Data shown for patients with HIV receiving antiretroviral therapy and with most recent CD4 count of at least 500 cells per μL; background HIV-negative incidence for 2009. The Lancet HIV 2015 2, e243-e251DOI: (10.1016/S2352-3018(15)00063-6) Copyright © 2015 Elsevier Ltd Terms and Conditions